Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
8
×
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
merck
8
×
national
8
×
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
8
×
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
8
×
wisconsin top stories
clinical trials
eli lilly
moderna
pfizer
deals
startups
abbvie
alzheimer's disease
amgen
bristol-myers squibb
cancer immunotherapy
What
bio
8
×
roundup
companies
drug
life
moves
science
week
buy
debut
growing
nash
new
news
patients
talk
acquisitions
advantages
alliance
approval
approved
arena’s
bar
becker
biggest
billions
biogen’s
biopharmaceutical
black
bounty
brings
bristol
build
calls
ceo
changing
cig
color
comeback
company’s
Language
unset
Current search:
cancer
×
bio
×
" san francisco blog main "
×
" wisconsin blog main "
×
merck
×
national
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
4 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
5 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
5 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: Moderna’s IPO, Arena’s Comeback, E-Cig Survey & More